Described herein are pharmaceutical packaging methods which stop oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive drugs, this kind of methods which include a syringe with the oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with quite reduced permeability to oxygen and compris